1. Home
  2. ANIX vs GNSS Comparison

ANIX vs GNSS Comparison

Compare ANIX & GNSS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ANIX
  • GNSS
  • Stock Information
  • Founded
  • ANIX 1982
  • GNSS N/A
  • Country
  • ANIX United States
  • GNSS United States
  • Employees
  • ANIX N/A
  • GNSS N/A
  • Industry
  • ANIX Biotechnology: Pharmaceutical Preparations
  • GNSS Consumer Electronics/Appliances
  • Sector
  • ANIX Health Care
  • GNSS Consumer Staples
  • Exchange
  • ANIX Nasdaq
  • GNSS Nasdaq
  • Market Cap
  • ANIX 87.1M
  • GNSS 80.7M
  • IPO Year
  • ANIX 1987
  • GNSS N/A
  • Fundamental
  • Price
  • ANIX $3.39
  • GNSS $2.60
  • Analyst Decision
  • ANIX Strong Buy
  • GNSS Strong Buy
  • Analyst Count
  • ANIX 1
  • GNSS 1
  • Target Price
  • ANIX $7.00
  • GNSS $3.50
  • AVG Volume (30 Days)
  • ANIX 65.6K
  • GNSS 117.8K
  • Earning Date
  • ANIX 09-04-2024
  • GNSS 08-08-2024
  • Dividend Yield
  • ANIX N/A
  • GNSS N/A
  • EPS Growth
  • ANIX N/A
  • GNSS N/A
  • EPS
  • ANIX N/A
  • GNSS N/A
  • Revenue
  • ANIX N/A
  • GNSS $35,063,000.00
  • Revenue This Year
  • ANIX N/A
  • GNSS N/A
  • Revenue Next Year
  • ANIX N/A
  • GNSS $144.06
  • P/E Ratio
  • ANIX N/A
  • GNSS N/A
  • Revenue Growth
  • ANIX N/A
  • GNSS N/A
  • 52 Week Low
  • ANIX $2.15
  • GNSS $1.51
  • 52 Week High
  • ANIX $5.13
  • GNSS $3.92
  • Technical
  • Relative Strength Index (RSI)
  • ANIX 57.65
  • GNSS 54.26
  • Support Level
  • ANIX N/A
  • GNSS N/A
  • Resistance Level
  • ANIX $2.83
  • GNSS $2.78
  • Average True Range (ATR)
  • ANIX 0.14
  • GNSS 0.20
  • MACD
  • ANIX 0.01
  • GNSS -0.07
  • Stochastic Oscillator
  • ANIX 98.24
  • GNSS 93.53

About ANIX Anixa Biosciences Inc.

Anixa Biosciences Inc, a cancer-focused biotechnology company, developing vaccines and therapies that are focused on critical unmet needs in oncology. The company is developing both diagnostics and therapeutics to detect cancer early, which is curable, and to treat those afflicted once diagnosed. Its segment includes CAR-T Therapeutics; Cancer Vaccines; Anti-Viral Therapeutics and others.

About GNSS Genasys Inc.

Genasys Inc is a provider of critical communications solutions designed to help keep people safe. The company is engaged in the design, development, and commercialization of directed and multidirectional sound technologies, voice broadcast products and location-based mass messaging solutions for emergency warning and workforce management. Its operating segment includes Hardware and Software. The company generates maximum revenue from the Hardware segment. Geographically, it derives a majority of revenue from the Americas region and also has its presence in the Asia Pacific and Europe, Middle East and Africa.

Share on Social Networks: